Dogwood Therapeutics DWTX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's accounts payable?
- Dogwood Therapeutics (DWTX) reported accounts payable of $144.4K in Q1 2026.
- How has Dogwood Therapeutics's accounts payable changed year-over-year?
- Dogwood Therapeutics's accounts payable decreased by 87.5% year-over-year, from $1.15M to $144.4K.
- What is the long-term trend for Dogwood Therapeutics's accounts payable?
- Over 4 years (2021 to 2025), Dogwood Therapeutics's accounts payable has grown at a 15.0% compound annual growth rate (CAGR), from $1.71M to $3M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.